Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage

RA Lang, D Metcalf, RA Cuthbertson, I Lyons… - Cell, 1987 - cell.com
RA Lang, D Metcalf, RA Cuthbertson, I Lyons, E Stanley, A Kelso, G Kannourakis…
Cell, 1987cell.com
Transgenic mice carrying the murine granulocytemacrophage colony stimulating factor (GM-
CSF) gene expressed from a retroviral promoter exhibit elevated levels of GM-CSF in the
serum, urine, peritoneal cavity, and eye. The eyes of transgenic mice are opaque, contain
accumulations of macrophages, and develop retinal damage. Similarly, lesions containing
macrophages develop in striated muscle. The mice also display an accumulation of large,
often multinucleate, activated macrophages in the peritoneal and pleural cavities. The …
Summary
Transgenic mice carrying the murine granulocytemacrophage colony stimulating factor (GM-CSF) gene expressed from a retroviral promoter exhibit elevated levels of GM-CSF in the serum, urine, peritoneal cavity, and eye. The eyes of transgenic mice are opaque, contain accumulations of macrophages, and develop retinal damage. Similarly, lesions containing macrophages develop in striated muscle. The mice also display an accumulation of large, often multinucleate, activated macrophages in the peritoneal and pleural cavities. The transgene is transcribed in peritoneal cells, as well as in eyes and infiltrated striated muscle. A high proportion of transgenic mice die with muscle wasting when aged 2-4 months, possibly because of macrophage activation resulting from the high levels of GM-CSF.
cell.com